Related references
Note: Only part of the references are listed.Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping
Katrina Rack et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
Silvia Ramos-Campoy et al.
HAEMATOLOGICA (2022)
Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia
Dolors Costa et al.
GENES CHROMOSOMES & CANCER (2022)
Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL)
Anna Puiggros et al.
CANCERS (2022)
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
Alexander C. Leeksma et al.
HAEMATOLOGICA (2021)
High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia
Othman Al-Sawaf et al.
BLOOD (2020)
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Isidro Cortes-Ciriano et al.
NATURE GENETICS (2020)
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes
Ferran Nadeu et al.
BLOOD (2020)
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
Arnon P. Kater et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Chromoanagenesis: cataclysms behind complex chromosomal rearrangements
Franck Pellestor
MOLECULAR CYTOGENETICS (2019)
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Panagiotis Baliakas et al.
BLOOD (2019)
Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups
A. Burns et al.
LEUKEMIA (2018)
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL
J. R. Brown et al.
LEUKEMIA (2018)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
Single-agent ibrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
Susan O'Brien et al.
BLOOD (2018)
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in he United States
Anthony R. Mato et al.
HAEMATOLOGICA (2018)
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in he United States
Anthony R. Mato et al.
HAEMATOLOGICA (2018)
Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia
Kathy Chun et al.
CANCER GENETICS (2018)
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
Anna Puiggros et al.
ONCOTARGET (2017)
Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients
Marie Jarosova et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI
Gian Matteo Rigolin et al.
BLOOD (2017)
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax
Mary Ann Anderson et al.
BLOOD (2017)
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy
Carmen Diana Herling et al.
BLOOD (2016)
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Asher Chanan-Khan et al.
LANCET ONCOLOGY (2016)
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
H. Parker et al.
LEUKEMIA (2016)
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Complex Karyotype is a Stronger Predictor Than Del(17p) for an Inferior Outcome in Relapsed or Refractory Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib-Based Regimens
Philip A. Thompson et al.
CANCER (2015)
Chromothripsis and Kataegis Induced by Telomere Crisis
John Maciejowski et al.
CELL (2015)
Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia with Chromothripsis in an Old Woman
Li Tan et al.
CHINESE MEDICAL JOURNAL (2015)
Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia
Itziar Salaverria et al.
GENES CHROMOSOMES & CANCER (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Chromothripsis from DNA damage in micronuclei
Cheng-Zhong Zhang et al.
NATURE (2015)
Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens
Haoyang Cai et al.
BMC GENOMICS (2014)
Chromoplexy: A New Category of Complex Rearrangements in the Cancer Genome
Michael M. Shen
CANCER CELL (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes
Tae-Min Kim et al.
GENOME RESEARCH (2013)
Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis
L. Bassaganyas et al.
LEUKEMIA (2013)
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations
Jennifer Edelmann et al.
BLOOD (2012)
DNA breaks and chromosome pulverization from errors in mitosis
Karen Crasta et al.
NATURE (2012)
Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements
Andrew J. Holland et al.
NATURE MEDICINE (2012)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
